VNN2
Basic information
Region (hg38): 6:132743870-132763459
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VNN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 4 | 3 |
Variants in VNN2
This is a list of pathogenic ClinVar variants found in the VNN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-132744311-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
6-132744319-T-G | not specified | Uncertain significance (Jul 26, 2022) | ||
6-132744320-G-T | not specified | Uncertain significance (May 09, 2023) | ||
6-132744383-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
6-132744386-A-G | not specified | Uncertain significance (May 31, 2023) | ||
6-132744398-G-C | not specified | Uncertain significance (Mar 29, 2023) | ||
6-132744475-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
6-132749813-G-T | not specified | Uncertain significance (Apr 22, 2022) | ||
6-132749816-C-T | not specified | Likely benign (Nov 09, 2023) | ||
6-132749832-A-C | not specified | Uncertain significance (Dec 20, 2022) | ||
6-132751156-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
6-132751167-C-T | Benign (Jan 25, 2018) | |||
6-132751180-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
6-132751198-C-T | not specified | Uncertain significance (Apr 04, 2023) | ||
6-132751227-A-T | not specified | Uncertain significance (Dec 20, 2023) | ||
6-132751228-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
6-132751295-T-A | not specified | Uncertain significance (May 29, 2024) | ||
6-132751329-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
6-132751435-C-T | not specified | Uncertain significance (May 24, 2024) | ||
6-132751489-T-G | not specified | Uncertain significance (Apr 26, 2023) | ||
6-132752566-C-A | not specified | Uncertain significance (Jun 24, 2022) | ||
6-132752658-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
6-132752672-C-A | Likely benign (Jan 01, 2023) | |||
6-132755923-A-G | not specified | Uncertain significance (Aug 10, 2021) | ||
6-132755930-G-T | Malignant tumor of prostate | Uncertain significance (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VNN2 | protein_coding | protein_coding | ENST00000326499 | 7 | 19590 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.45e-15 | 0.00656 | 125583 | 0 | 162 | 125745 | 0.000644 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.467 | 299 | 277 | 1.08 | 0.0000134 | 3391 |
Missense in Polyphen | 86 | 85.633 | 1.0043 | 1106 | ||
Synonymous | -0.469 | 111 | 105 | 1.06 | 0.00000549 | 1031 |
Loss of Function | -0.374 | 21 | 19.2 | 1.09 | 9.64e-7 | 233 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00114 | 0.00112 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00148 | 0.00147 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000725 | 0.000721 |
Middle Eastern | 0.00148 | 0.00147 |
South Asian | 0.000812 | 0.000719 |
Other | 0.000822 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Amidohydrolase that hydrolyzes specifically one of the carboamide linkages in D-pantetheine thus recycling pantothenic acid (vitamin B5) and releasing cysteamine. Involved in the thymus homing of bone marrow cells. May regulate beta-2 integrin-mediated cell adhesion, migration and motility of neutrophil. {ECO:0000269|PubMed:11491533}.;
- Pathway
- Pantothenate and CoA biosynthesis - Homo sapiens (human);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins;Metabolism;Vitamin B5 (pantothenate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- rvis_EVS
- 1.33
- rvis_percentile_EVS
- 94.21
Haploinsufficiency Scores
- pHI
- 0.271
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.900
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- pantothenate metabolic process
- Cellular component
- extracellular region;plasma membrane;anchored component of membrane
- Molecular function
- pantetheine hydrolase activity